EndoChoice® to Present at Investor Conferences in February 2016

Jan 26, 2016, 08:00 ET from EndoChoice

ALPHARETTA, Ga., Jan. 26, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE:  GI) announced today that Mark Gilreath, Founder and Chief Executive Officer, and David Gill, Chief Financial Officer are scheduled to participate in three investor conferences in February 2016.

 

Event:

LEERINK Partners 5th Annual Global Healthcare Conference

Format:

Presentation and One-on-One Meetings 

Date:  

Thursday, February 11, 2016

Time: 

11:35 a.m. ET

Location: 

New York, NY

Participant:

David Gill, Chief Financial Officer



Event:

2016 RBC Capital Markets Global Healthcare Conference

Format:

Presentation and One-on-One Meetings

Date:  

Wednesday, February 24, 2016

Time:

10:00 a.m. ET

Location: 

New York, NY

Participant: 

David Gill, Chief Financial Officer



Event:  

2016 BTIG MedTech Conference

Format:  

One-on-One Meetings Only

Date:

Wednesday, February 24 - Friday, February 26, 2016

Location:  

Snowbird, UT

Participant: 

Mark Gilreath, Founder and Chief Executive Officer

                          

Audio webcasts of the Company's presentations will be available by visiting the investor relations section of EndoChoice's web site at www.endochoice.com. Replays of the presentations will be available for 90 days.

About EndoChoice:
Based near Atlanta, Georgia, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

Company Contact: David Gill, Chief Financial Officer 678-585-1040  david.gill@endochoice.com   

Investor Contacts: Nick Laudico or Zack Kubow The Ruth Group 646-536-7030 / 7020 nlaudico@theruthgroup.com zkubow@theruthgroup.com

 

SOURCE EndoChoice



RELATED LINKS

http://www.endochoice.com